Get startedLog in
    Picture of Bristol-Myers Squibb Co logo

    BMY — Bristol-Myers Squibb Co News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareBalancedLarge CapSuper Stock
    All News

    Brief: Bristol Myers Expects 2026 Adj EPS $6.05 To $6.35 vs IBES Estimate $6.02

    Picture of Bristol-Myers Squibb Co logoBristol-Myers Squibb Co
    05/02/2026 11:59
    Feb 5 (Reuters) - Bristol-Myers Squibb Co BMY.N:

BRISTOL MYERS Q4 ADJUSTED EPS INCLUDES NET IMPACT OF $-0.60 DUE TO ACQUIRED IPRD CHARGES & LICENSING INCOME

BRISTOL MYERS Q4 REVENUE $12.5 BILLION VERSUS IBES ESTIMATE $12.28 BILLION

BRISTOL MYERS OUTLOOK 2026 REVENUE ABOUT $46.0 BILLION TO $47.5 BILLION VERSUS IBES ESTIMATE $44.16 BILLION

BRISTOL MYERS Q4 ADJUSTED EPS $1.26 VERSUS IBES ESTIMATE $1.12

BRISTOL MYERS OUTLOOK 2026 ADJUSTED EPS $6.05 TO $6.35 VERSUS IBES ESTIMATE $6.02

BRISTOL MYERS OUTLOOK 2026 ELIQUIS WW REVENUE GROWTH 10% - 15%

Further company coverage: BMY.N

    Recent news on Bristol-Myers Squibb Co

    See all news